Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

1,227.20INR
11:29am BST
Change (% chg)

Rs-2.65 (-0.22%)
Prev Close
Rs1,229.85
Open
Rs1,225.50
Day's High
Rs1,233.55
Day's Low
Rs1,225.10
Volume
38,779
Avg. Vol
16,477
52-wk High
Rs1,800.05
52-wk Low
Rs1,225.00

Revenue & Earnings Per Share

 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 8,176.00 8,176.00 8,176.00 --
Year Ending Mar-19 5 32,594.00 33,724.00 31,949.00 --
Year Ending Mar-20 5 35,517.60 36,845.00 34,143.00 37,040.40
Year Ending Mar-21 5 39,554.40 41,567.00 36,904.00 --
Earnings (per share)
Year Ending Mar-19 5 24.77 26.60 24.00 --
Year Ending Mar-20 5 29.01 32.20 25.59 30.22
Year Ending Mar-21 5 33.57 39.60 28.97 --
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 62.45 29.30 32.55
P/E High - Last 5 Yrs. -- 43.17 48.11
P/E Low - Last 5 Yrs. -- 22.71 23.41
Beta 0.17 0.86 0.87
Price to Sales (TTM) 14.01 6.60 8.44
Price to Book (MRQ) -- 5.12 5.27
Price to Tangible Book (MRQ) -- 5.84 6.74
Price to Cash Flow (TTM) 174.34 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield 1.24 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 4.00 4.71
Payout Ratio(TTM) 0.00 42.19 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.04
Sales - 5 Yr. Growth Rate -- 10.48 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 46.17 48.19
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.46
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) -- 2.87 2.98
LT Debt to Equity (MRQ) -- 8.87 11.35
Total Debt to Equity (MRQ) -- 12.87 16.04
Interest Coverage (TTM) -- 32.47 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 52.06 52.36
Gross Margin - 5 Yr. Avg. -- 49.67 50.39
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 17.26 12.41
Operating Margin (TTM) 33.89 13.47 5.62
Operating Margin - 5 Yr. Avg. -- 13.69 8.00
Pre-Tax Margin (TTM) 33.89 11.82 4.64
Pre-Tax Margin - 5 Yr. Avg. -- 14.09 8.28
Net Profit Margin (TTM) 23.12 8.73 1.37
Net Profit Margin - 5 Yr. Avg. -- 10.58 4.69
Effective Tax Rate (TTM) 31.77 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 928,391,941 819,624,671
Net Income/Employee (TTM) 718,922 105,138,175 92,776,869
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.42
Asset Turnover (TTM) -- 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.98 10.65
Return on Assets - 5 Yr. Avg. -- 12.41 11.77
Return on Investment (TTM) -- 14.23 13.82
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -- 15.46 15.24
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -2.64 99 30
13 Week -6.52 -7.86 99 42
26 Week -11.71 -17.56 99 43
52 Week -17.27 -26.91 99 11
YTD -11.53 -25.96 99 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.57%
# of Holders: 17
Total Shares Held: 19,601,471
3 Mo. Net Change: -1,511,916
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 4
# Reduced Positions: 5
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.